Please try another search
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research, development, production, and marketing of various pharmaceutical products in China and internationally. The company offers Chinese medicine granules, finished pharmaceutical products, raw materials and excipients, medical devices, healthcare services, and smart supply chain for pharmaceutical and medical devices. It provides its products in the areas of severe disease, cardiovascular, cerebrovascular system, respiratory system, neurodegenerative, and anti-tumor. The company was founded in 1996 and is based in Tianjin, China.
Name | Age | Since | Title |
---|---|---|---|
Dan Zheng | 59 | 2022 | GM & Vice Chairman |
Yao Xiao Qing | 59 | 2022 | Chairman |
Shengtian Wang | 73 | 2017 | Independent Director |
Li Li | 63 | 2020 | Independent Director |
Wu Jun Lan | 49 | 2011 | Executive GM, CFO & Executive Director |
Tao Gong | 55 | 2020 | Independent Director |
Chun Xu Li | 54 | 2024 | Deputy GM, Chief Administrative Officer & Director |
Peng Fei Tu | 61 | 2020 | Independent Director |
Wu Sun | 55 | 2019 | Deputy GM, Accounting Supervisor & Director |
Dan Liang | 43 | 2013 | Employee Representative Member of Supervisory Board & Securities Affairs Representative |
Juan Chen | 47 | 2023 | Director |
Sen Lin | 42 | 2024 | Director |
Hui Hu | 52 | 2023 | Supervisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review